dr. axel grothey on the side effect profile of regorafenib in metastatic colorectal cancer
Published 11 years ago • 205 plays • Length 2:03Download video MP4
Download video MP3
Similar videos
-
1:47
dr. axel grothey on the time course of regorafenib-associated adverse events
-
1:35
dr. axel grothey on bevacizumab beyond progression in metastatic colorectal cancer
-
1:53
the role of sidedness in colorectal cancer
-
1:43
axel grothey, md | what is signatera?
-
5:23
what you need to know about colorectal cancer
-
31:38
allycon 2020: managing colorectal cancer side effects, including bowel symptoms and habits
-
1:00:16
gut check: a journey through colorectal cancer, prevention and treatment | grace cancer foundation
-
0:57
dr. axel grothey examines the use of adjuvant oxaliplatin in colon cancer
-
4:53
debate: salvage therapy for mcrc? - tas-102 followed by regorafenib
-
1:49
dr. george demetri describes the mechanism of action of regorafenib in gist
-
1:28
surivival benefit of regorafenib in correct and concur trials
-
1:55
dr. grothey describes the phase iii correct study
-
9:34
regorafenib in colorectal cancer
-
1:30
dr. nancy l. lewis discusses the correct trial for regorafenib in metastatic colorectal cancer
-
11:02
debate 3: salvage therapy for mcrc? - regorafenib
-
1:04
dr. eckhardt on the role of regorafenib in colorectal cancer
-
2:58
treatment response and side effects with regorafenib
-
1:27
dr. axel grothey on differences between correct and concur studies in mcrc
-
13:17
key insights: updates in colorectal cancer
-
1:12
axel grothey, md, on the use of regorafenib in the management of advanced crc
-
1:26
an overview of the lume 1 and 2 trials
-
1:21
dr. george demetri explains the side effects associated with regorafenib